Medical Devices Startups

Minnesota Medical Technologies develops and manufactures continence care products, specifically fecal incontinence management devices for individual patients. The company is based in Stewartville, Minnesota, and leverages over 30 years of expertise in silicone technology and medical device manufacturing.

1 investor

Mobius Scientific develops treatments for age-related macular degeneration and other retinal diseases by targeting the root cause of vision loss. The company serves patients with progressive vision loss globally.

1 investor

MOC Biotechnologies builds hybrid 4D bioprinters and biomechatronic systems that print hard and soft tissue, organs, and cell scaffolds using hydrogels, polymers, and drugs for preclinical drug discovery and regenerative medicine. It serves research centers, universities, laboratories, and preclinical CROs, with applications including cancer research.

1 investor

Model Health is a software company that uses artificial intelligence and smartphone video to perform biomechanical analysis of human movement. The platform serves physiotherapists, medical staff, coaches, and sports organizations seeking clinical-grade movement insights for injury prevention, rehabilitation, and performance optimization.

1 investor

ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development. It serves pharmaceutical companies, contract research organizations, academic labs, and institutional animal care committees by extracting study parameters from scientific literature to accelerate drug discovery timelines.

1 investor

MODJAW builds a 4D digital dental technology that captures and integrates jaw movement in real time into the digital workflow, used by dentists, prosthodontists, and orthodontists for diagnosis, treatment planning, and restoration design. The system supports full-mouth rehabilitations, TMJ dysfunction diagnostics, and prosthetic treatments.

1 investor

Modulight develops a platform to treat severe neurological diseases through scientific innovation and clinical expertise.

1 investor

Molecular Designs develops and sells research assays and molecular diagnostic panels designed to run on standard PCR platforms, serving research labs seeking cost-effective and efficient testing solutions. The company offers direct-to-customer purchasing with customization options and supply chain support.

1 investor

Molecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.

1 investor

MT develops cancer-specific molecular imaging agents (probes) targeting a common oncoprotein in the tumor microenvironment, intended for use with imaging modalities such as CT, PET, MRI, SPECT and ultrasound. The agents are aimed at early detection and diagnosis of aggressive tumors across multiple cancer types for clinical cancer management.

1 investor

Molecular Instruments develops HCR (hybridization chain reaction) imaging products for enzyme-free, multiplex, quantitative in situ hybridization and immunofluorescence, enabling detection of RNA and protein targets. Its products serve researchers in life sciences performing high-resolution imaging and expression profiling of cells and tissue samples.

1 investor

Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.

1 investor

Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.

1 investor

MoleMap provides skin cancer detection and diagnosis services, including full-body mole mapping, dermatologist-diagnosed skin checks, imaging with ongoing monitoring, and skin cancer treatment. It serves individuals and workplaces through clinics in New Zealand and Australia, with additional GP referral and workplace screening programs.

1 investor

MoleSense is a Switzerland-based company whose website references future health-related products, applications, wearable devices, biomarker and clinical data processing. The page is a privacy policy and gives limited detail, but suggests a focus on health monitoring or diagnostics involving wearables and biomarker data.

1 investor

Mölnlycke is a MedTech company that develops wound care, surgical, and antiseptic solutions for healthcare providers and professionals globally. The company serves healthcare systems and providers seeking to improve patient outcomes while reducing environmental impact.

1 investor

Momentum Clinical Research (formerly PCRN) operates a network of 19 clinical research sites across Australia and New Zealand, conducting phase I to IV clinical trials across most therapeutic areas. It partners with pharmaceutical and biotech companies to run studies and recruits local participants as trial volunteers.

1 investor

Mon4t provides quantitative neurological assessment technology that enables remote testing and monitoring of neurological symptoms for clinical research, drug development, telemedicine, and screening applications. The platform serves patients, researchers, clinicians, and telehealth providers across preclinical and commercial stages of care.

1 investor

Monarch Biosciences develops and commercializes medical device and biotechnology products based on Thin Film Nitinol technology.

1 investor

Monarch Health Systems develops a platform for pediatric surgical care quality and safety management. The platform helps children's hospitals track and improve clinical outcomes and operational performance.

1 investor

MTI operates an FDA-cleared respiratory testing platform that unifies spirometry and lung-function testing across clinic and home settings, using real-time coaching to produce standardized, analysis-ready data. It serves clinicians, health systems and hospitals, and clinical trial sponsors seeking earlier respiratory diagnosis and remote monitoring.

1 investor

Monivent AB is a publicly traded Swedish healthcare company that manufactures medical monitoring products for clinical training and patient care.

1 investor

Monteris develops minimally invasive laser ablation technology (LITT) used to treat brain conditions including oncology tumors and drug-resistant epilepsy. It focuses on generating prospective multi-center clinical evidence to support physicians treating these patients.

1 investor

Morphle Labs builds robotic microscopy systems that automate the diagnostic analysis of cancer samples in laboratory settings.

1 investor